All In MedTech

Device Trial Radar · NCT03202472

Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery

Pilot Trial Evaluating a Miniature Radiofrequency Tag for Localization of Non-palpable Breast Lesions for Surgery

Last checked: Nov 19, 2026Latest source record: Jul 24, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

50

Actual

Start

Aug 3, 2017

Primary completion

Jan 12, 2018

Study completion Feb 1, 2019

Sponsor

Lead sponsor
Jonsson Comprehensive Cancer CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
AstraZeneca
First posted
Jun 28, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
Yes
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot clinical trial studies radiofrequency technology in locating non-palpable breast lesions in patients undergoing surgery. Placing a miniature radiofrequency tag or microchip in the breast lesion before surgery and using a handheld device to guide doctors during surgery may improve surgical outcomes in patients with non-palpable breast lesions.

Conditions

  • Breast Neoplasm
  • Lesion

Interventions

  • Implanted Medical DeviceDevice

    Radiofrequency tag

  • MammographyProcedure

    Undergo mammogram for image-guided placement of radiofrequency tag

  • Questionnaire AdministrationOther

    Ancillary studies

  • Radiofrequency (RFID) -Guided LocalizationProcedure

    Undergo radiofrequency-guided localization

  • UltrasonographyProcedure

    Undergo ultrasound for image-guided placement of radiofrequency tag

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patients With Successful Placement of the Radiofrequency Tag Under Radiographic Guidance Confirmed by MammographyTime frame: at time of device placement, confirmed by mammography
  2. Patients With Successful Retrieval of the Radiofrequency Tag Confirmed by Specimen RadiographyTime frame: at time of surgery, within 30 days of tag implant

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UCLA / Jonsson Comprehensive Cancer Center

    Los Angeles, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.